logo
Plus   Neg
Share
Email

Lanxess Q3 Profit Down; Realigns Organometallics Business - Quick Facts

Specialty chemicals company Lanxess AG (LNXSF.PK) reported that its third-quarter net income declined 13.8 percent to 69 million euros from last year's 80 million euros, mainly due to higher depreciation. Earnings per share decreased by 10.2 percent to 0.79 euros, due to the lower average number of shares outstanding after the share buyback program.

EBITDA pre exceptionals was 267 million euros, down 3.6 percent from the prior year. Earnings were negatively impacted in particular by lower demand from the automotive industry and the weak chrome ore business. However, this was almost offset by the company's stable portfolio and advantageous exchange-rate effects, especially from the strong U.S. dollar.

Group sales in the third quarter of 2019 were 1.78 billion euros on a par with the previous year's level.

The company expects its EBITDA pre exceptionals in the fourth quarter to be slightly better than in the previous year.

For the full year 2019, the company expects its EBITDA pre exceptionals to be between 1.000 billion euros and 1.050 billion euros, compared to 1.016 billion euros reported last year.

Lanxess said it is realigning its organometallics business in order to focus on profitable growth segments in the future. It is investing an amount in the mid-single-digit millions of euros at its location in Bergkamen, Germany, to expand production of aluminum-based organometallics, which are used as catalysts in the production of high-quality plastics.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
RELATED NEWS
Follow RTT